Company Group Chairman, Asia Pacific
Johnson & Johnson Medical Devices Companies
Chairman Johnson & Johnson China
Vladimir Makatsaria is Company Group Chairman, leading the Medical Devices Group in Asia Pacific. Additionally, he serves as the Chairman of Johnson & Johnson China, with enterprise-wide responsibilities.
Vladimir began his career with Johnson & Johnson as a sales representative in Russia in 1996. He went on to hold several general management positions of increasing responsibility, including Managing Director in Russia, Area Director in Eastern Europe, President in Europe Middle East & Africa.
Vladimir is the Chairman of the Asia Pacific MedTech Association and a member of the Business Advisory Board of the Singapore Management University.
Vladimir holds a Bachelor’s degree in Physiology and Master’s degrees in Healthcare Administration and Business Administration from the University of Minnesota.
Anna Maria Braun
President, Asia Pacific and
Member of the Management Board,
B.Braun Melsungen AG.
Anna Maria Braun is President, Asia Pacific and Member of the Management Board, B. Braun Melsungen AG.
As President of Asia Pacific, she is responsible for the Group’s pharmaceutical and medical technology business in the entire region.
Based in the Regional Headquarters in Penang, Malaysia, Ms. Braun also oversees one of the Group’s largest production sites.
Ms. Braun is a qualified Attorney-at Law with a degree in Law from the University of Freiburg, Germany and a Masters in Law from Georgetown University in Washington, DC. She has been admitted to the Bar in Germany and in New York State, USA.
Anna Maria Braun is married and has two children.
Executive Vice President and President, Greater Asia
Becton Dickinson & Co.
James is currently the first Asian on Becton Dickinson’s Senior Leadership Management Committee reporting to the CEO. BD is a leading medical technology company engaged principally in the manufacture and sale of medical supplies, devices, instrument systems and reagents.
James joined BD in 1994 from Seagate International, as Engineering and Facility Manager of BD Medical (Singapore), and after a 3-year assignment in R&D, he became Plant Manager in year 2000. In 2003, he was promoted as Director of Operations, Asia Pacific, where he was responsible for the regional Manufacturing organizations and Supply Chain function, covering plants from Bawal in India to Suzhou in China. In April 2008, he was appointed as Vice President for Central and Asia Pacific responsible for Central Asia Business Management and the overall support functions for entire Asia Pacific region.
Four years later he was appointed as President of Greater Asia and an Executive member of the Company. Mr. James Lim leads Greater Asia that covers Japan, China, Taiwan/HK, Australia, and New Zealand, Korea, South-East Asia, India and Pakistan.
James had his earlier education in Malaysia but studied at the Nanyang Technological University where he graduated with a Mechanical Engineering Degree. James occasionally participates as a panel member at regional Business Leader’s meetings to learn more from others and sharing different views on how to tackle business issues.
In July 2014, James was awarded the Leading CEO, by the Singapore Human Resources Institute (SHRI) for his “dedication, championship of innovative and effective HR ideas and practices, and demonstration of leadership in the industry.”
Divisional Vice President, Asia Pacific and Japan
Harvinder Singh heads Abbott Vascular’s Asia Pacific and Japan business and is based in Singapore. Harvinder has been with Abbott for 16 years and in the healthcare industry for over 25 years. His work experience includes both medical device and pharmaceuticals.
In his previous roles, Harvinder has been President of Abbott Vascular Japan, General Manager of China & North Asia, Head of marketing and strategy APAC and Head of sales in India. He has also worked with Eli Lilly India in marketing role.
Harvinder’s educational background includes an undergraduate degree in Chemistry and Biology, and an MBA in Marketing. He has attended various management development programs in the US including the Program for Leadership development at the Harvard Business School.
Eric Van Oppens
President, Asia & Russia
Eric Van Oppens is the Region President, Asia & Russia at Alcon. He leads more than 3,300 associates across three different franchises – Pharmaceutical, Surgical and Vision Care. Mr. Van Oppens was appointed to this role on July 1, 2015. He is a member of the Alcon Executive Leadership Team.
Mr. Van Oppens has held a number of leadership roles in Novartis since he joined the group in 2005. He has lived and worked in Asia since 2009 based in the Philippines, South Korea and Singapore. Prior to Alcon, he was the Head of Asia Cluster for Novartis Pharma Division from 2013, leading 10 country pharmaceutical operations organizations including Korea, Taiwan, Thailand, Indonesia, Malaysia, Vietnam, Indonesia, Bangladesh, Pakistan and Singapore, Myanmar, Sri Lanka & Cambodia. Before that, he served as Novartis Country President and Head of Novartis Pharma in Korea and previously also led the Philippines, Singapore, and Indonesia Cluster. Eric was also Head of Marketing & Sales for most of what is now AMAC across Asia, Middle East, Africa, and CIS in 2008 in Novartis Pharma. Eric’s Novartis Pharma career began in Morocco, where he served as Country Pharmaceutical Organization Head Morocco and North Africa Cluster Head.
Prior to joining Novartis, Eric served in management roles at Bristol-Myers Squibb and Baxter based in Belgium, Italy and North Africa.
Eric holds a Bachelor’s degree in Economics from the ICHEC Brussels Management School, a Master’s degree in Economics from Saint-Louis University in Brussels, and a Master’s degree in Political Science from Université Catholique de Louvain in Louvain, Belgium. He also completed the Executive Education Program in Business Finance at Harvard Business School.
Executive Vice President and President, Asia-Pacific Middle East & Africa
Supratim Bose is Executive Vice President and President, Asia-Pacific, Middle East & Africa for Boston Scientific, and a member of its Executive Committee. In this role, Supratim oversees the Company’s business and growth opportunities across Asia Pacific, Middle East & Africa, the world’s fastest growing region.
Before joining Boston Scientific in January 2012, Supratim was Founder and Chief Executive Officer of Singapore-based Bose Consulting Group, which specialized in strategic management consulting services for the healthcare industry. Prior to that, he was with Johnson & Johnson (J&J) for nearly 30 years, where he concluded his tenure as Company Group Chairman of its Medical Devices and Diagnostics (MD&D) business. In that role, he managed J&J’s MD&D companies throughout Asia-Pacific, including Japan, having pioneered its entry in all emerging markets in Asia including China, India, and Vietnam.
During his tenure, he also created the company’s research and development capability in the region and led the development and growth of local talent. Under Supratim’s leadership, the organization partnered closely with key external stakeholders to shape the healthcare environment, and was recognized by external agencies as one of the top companies to work for in Asia-Pacific.
Supratim joined J&J Ltd. India in 1981, and held a variety of management positions of increasing responsibility leading up to his appointment as Company Group Chairman of MD&D. He has extensive and proven experience in building markets in this region. Prior to J&J, he served at one of the top growing pharmaceutical start-ups in India.
Supratim earned a B.Sc. In Chemistry/Physics, a M.Sc. In Biophysics and a Master in Management Studies (MMS) from the Jamnalal Bajaj Institute of Management Studies at the University of Bombay. He served as a member of the Board of Directors at CareFusion Corporation, Quattro Vascular Pte Ltd and Trireme Medical, and member of the Advisory Board at Singapore Management University’s Lee Kong Chian School of Business.
Senior Vice President and President, Asia Pacific
Bob is Senior Vice President and President, Asia Pacific at Medtronic, based in Singapore, and is a member of the Medtronic Executive Committee.
Previously, Bob was at Covidien plc from 2010 to 2014 where he served in roles of increasing responsibility – most recently as President, Emerging Markets preceded by President, Respiratory and Monitoring Solutions and Vice President and General Manager of Patient Monitoring. He has also held leadership positions at GE Healthcare and IBM.
Among other industry involvement, Bob is a Fellow of the American College of Healthcare Executives (FACHE), as well as serving on the Boards of the Asia Pacific Medical Technology Association (APACMed), US-ASEAN Business Council, the Anesthesia Patient Safety Foundation (APSF), and the National Patient Safety Foundation (NPSF).
Bob holds a bachelor’s degree in marketing from Cleveland State University and a master’s degree in finance and information systems from Case Western Reserve University.
Massimiliano (Max) Colella
Senior Vice President Asia Pacific
Smith & Nephew
During his 25-year career in the Medical Device Industry, Massimiliano has held both national and international roles, working for Johnson & Johnson (21ys) and Smith & Nephew (4ys).
Previous roles included Senior Vice President Emerging Market at Smith & Nephew (Dubai); Regional Managing Director Central & Eastern Europe at Johnson & Johnson (Prague); Managing Director Mediterranean Region at Johnson & Johnson (Rome).
Massimiliano also has held high profile roles with various trade associations including Board Member of CzechMed (Czech Republic); Board Member of American Chamber of Commerce (Czech Republic); and Board Member of Assobiomedica (Italy). He is currently Member of British Chamber of Commerce in Singapore.
Massimiliano, (49) is Italian and lives in Singapore with his wife and their two sons.
President, Asia Pacific
Stryker has a long and proud record of leadership, commitment and support for the Medical Technology industry in Asia Pacific. Stryker operates in a very broad range of MedTech sectors including theatre and hospital equipment, beds, surgical consumables, neuro technology and orthopaedic implants (maxillio-facial, spine, joints and trauma).
APACMed has a pivotal role to play in sustaining the development of our vibrant industry. It is in our interests to have a united and strong voice to represent our members with all key stakeholders including government, regulators, insurers/funders and other interest groups across diverse Asia Pacific markets.
This is a critical period as the Medtech industry matures into one that is now a significant contributor to the healthcare equation in Asia Pacific. Our customers and governments are increasingly coming under funding pressures which requires a different and smarter industry response, whilst regulators are seeking to raise the bar and cost of market access. We need to be able to articulate solutions and constructive reforms which will meet these challenges and also enable our industry to continue to flourish through responsible innovation which allows patients access to excellent, cost effective healthcare.
In this environment, we also need to ensure that APACMed remains relevant to all its members, remains viable with continuing growth in the membership base, and partners closely with both country and sister organisations such as EucoMed and AdvaMed.
I have worked for Stryker for 12 years with extensive experience across Asia Pacific. My current role is President Asia Pacific and I sit on the Stryker global Executive Leadership team.
I was formerly President of Stryker Australia/New Zealand and sat on the MTAA Board for 3 years, then recently President of Stryker Japan and sat on the AMDD Board for 2 years. I have front line experience of the challenges and issues in key markets in the region. I offer a unique set of skills and experience including 20 years of leadership in food and drinks businesses, consulting, as well as MedTech. I have governance experience, having worked closely with public listed company boards and voluntary organisations, am a member of the Institute of Company Directors and a qualified accountant. My detailed profile is available on LinkedIn.
I have recently relocated to Singapore and look forward to working with you and contributing significantly to our industry on a broader scale over the coming years.
Terumo Asia Holdings
Director & Senior Executive Officer
Hideo Arase is Director & Senior Executive Officer, Regional Representative, India and Asia-Pacific, Terumo Corporation; and Managing Director, Terumo Asia Holdings.
Currently based in Singapore, Mr Arase has been working since 1977 for Terumo Corporation, a Japan-headquartered global medical technology company.
Prior to his Singapore position, Mr Arase was President and CEO of Terumo Americas Holdings in the USA (2012-2015), CEO of Terumo Medical do Brasil in Brazil (2011-2012), Group President of Cardiac & Vascular Product Group in Japan (2009-2011), President & Chairman of Terumo Europe in Belgium (2006-2009), Business Manager of Interventional Systems, Terumo Europe in France (2001-2006), Manager of Terumo Europe, Interventional Systems in Belgium (1999-2001), and Branch Manager of Terumo Hong Kong Branch (1988-1991).
He has wide knowledge of business development and management practices through 38 years of experience in the medical-devices Industry.
Mr Arase’s post-graduate education comprises Management Innovation at Stanford University Biodesign Executive Education (2015), Communication Strategies at New York University Leonard N. Stern Business School (2013), an Advanced Coaching Programme from Leeds Metropolitan University (2009), and an MBA from United Business Institutes in Belgium (2001). Mr Arase received the GLOBIS Alumni Award 2010 for Revolution, and is the joint author of Dangerous Syndrome of Organization, published in September 1998.
Chief Executive Officer
Medical Technology Association of Australia
Ian is an experienced CEO and board director, with a history of leading and managing member based organisations. Ian’s previous CEO roles have included the Australian Dental Association (NSW); the Australian Orthopaedic Association; and Ortho Group, a private equity backed health business.
He has been successful in growing member-based organisations through implementing strategies to enhance member value proposition, increasing engagement and by applying savvy business acumen.
Ian was previously CEO of the Australian Dental Association, the membership body representing dentists in New South Wales, providing continuing education, member services and advocacy to support dentists and promote oral health. Prior to this, he held the role of CEO of Ortho Group Pty Limited, an Australian privately owned health business, comprising orthopaedic and sports medicine consulting and surgery, hospital and day surgeries, radiology centres and medical supplies businesses.
He has also held the role of CEO of the Australian Orthopaedic Association, a membership body representing orthopaedic surgeons, providing specialist training, continuing education and advocacy on behalf of the orthopaedic profession.
Ian holds an MBA from Macquarie University in Sydney and a Bachelor of Economics from the Australian National University.